Bambusa Therapeutics, Inc.

US$15.73As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BBTXHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE —
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM —
Mkt cap US$801.3M
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$15
(3.85%)
217.57%
Hold 5|11|4|7|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.18
0.19
0.19
0.20
16.17%
13.65%
5.02%
8.03%
Revenue$M
75.00
78.30
77.94
79.01
5.06%
11.20%
12.06%
11.31%
Peers (US$801.3M)
Cap (US$)
PE
796.2M
—
Capital
TTM
5Y
10Y
Leveragex
0.258
0.051
0.054
EBIT/Intx
2.034
0.346
0.330
Own earn%
(7.44)
(61.45)
(53.36)
Sh yield%
23.56
9.75
11.21
Owners
Insiders/Inst%
4.22
49.92
Short interest%
5.82
SBC / revenue%
2.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
14
Op margin range%
1–5
$1 testx
—
Incr. ROIC%
10